Representative before the EPO

Employment test 51 - 200 employees
Company dna venner shipley llp
operating since 1947
Headquarter in London and 5 offices
active in Legal Services and IP Consulting

Kathryn McNamara has worked on the following 16 EPO patent applications which have been published in the last five years:

EP11815949

COMBINATORY CANCER TREATMENT

IPC classification:
A61K 31/7056, A61K 31/706, A61K 45/06, A61P 35/00, A61P 35/02, C07H 19/056, C07H 19/12
Applicant:
Université de Montréal
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP11746258

ANTIMICROBIAL NANOPARTICLE CONJUGATES

IPC classification:
A61K 47/48
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP12721582

FILTER FOR A SMOKING ARTICLE

IPC classification:
A24D 3/04, A24D 3/06
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP12750728

NANOPARTICLES AND USES THEREOF

IPC classification:
A61K 47/48, A61K 49/00, A61K 49/18, A61P 9/04, A61P 9/10, A61P 35/00
Applicant:
Biocant - Associação De Transferência De Tecnologia
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP13717772

ANTIMICROBIAL COMPLEXES

IPC classification:
A01N 25/28, A01N 25/30, A01N 25/34, A01N 33/12, A01P 1/00
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP13776540

A SMOKING ARTICLE AND A METHOD OF MANFACTURING A SMOKING ARTICLE

IPC classification:
A24D 3/04
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
PATENT GRANTED
EP13799353

TREATMENT OF TOBACCO MATERIAL

IPC classification:
A24B 15/24
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP13799352

TREATMENT OF TOBACCO MATERIAL

IPC classification:
A24B 15/18
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP14714315

PACKAGING INSERT

IPC classification:
B65D 5/50, B65D 5/54, B65D 5/70, B65D 85/10
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP14742301

MATERIAL FOR INCLUSION IN A SMOKING ARTICLE

IPC classification:
A24D 1/18
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP11740761

SYNTHESIS AND ANTICANCER ACTIVITY OF ARYL AND HETEROARYL-QUINOLIN DERIVATIVES

IPC classification:
A61K 31/4709, A61K 31/4741, A61P 35/00, C07D 215/22, C07D 215/233, C07D 215/38, C07D 401/04, C07D 493/04, C07F 9/60, C07F 9/6558, C07F 9/6561
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
PATENT GRANTED
EP11715142

GAMMA-POLYGLUTAMIC ACID-BASED OCULAR IRRIGATING SOLUTIONS

IPC classification:
A61K 31/74, A61K 31/765, A61P 27/02
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12710532

SMOKING ARTICLES

IPC classification:
A24B 3/08, A24B 15/16, A24B 15/20, A24B 15/24, A24D 3/04, A24D 3/12, A24D 3/16
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
APPLICATION REFUSED
EP16181738

SYNTHESIS AND ANTICANCER ACTIVITY OF ARYL AND HETEROARYL-QUINOLIN DERIVATIVES

IPC classification:
A61K 31/4709, A61K 31/4741, A61P 35/00, C07D 215/22, C07D 215/233, C07D 215/38, C07D 401/04, C07D 493/04, C07F 9/60, C07F 9/6558, C07F 9/6561
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP15759204

CODING NUCLEOTIDE SEQUENCE OF MG53 PROTEIN WITH CODON OPTIMIZATION, RECOMBINANT AND USE THEREOF

IPC classification:
A61K 48/00, A61P 9/00, A61P 9/04, A61P 9/06, A61P 9/10, C12N 5/10, C12N 15/12, C12N 15/85
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP15757562

BIOMARKER ASSAY

IPC classification:
C12Q 1/48, G01N 33/487, G01N 33/49, G01N 33/53
Agent:
Kathryn McNamara, Venner Shipley LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature